Please note that Glide Pharmaceutical Technologies Ltd was Dissolved following Liquidation on 20 October 2018. Assets were purchased and are controlled by Enesi Pharma Limited.
View Top Employees from Glide Pharmaceutical TechnologiesWebsite | http://www.enesipharma.com |
Revenue | $5.6 million |
Funding | $4 million |
Employees | 4 (4 on RocketReach) |
Founded | 2001 |
Industry | Pharmaceutical Manufacturing |
Competitors | DFE Pharma, Glide Pharma, Surepharm Services Ltd, Zosano Pharma |
Looking for a particular Glide Pharmaceutical Technologies employee's phone or email?
The Glide Pharmaceutical Technologies annual revenue was $5.6 million in 2023.
John Watson is the Head of Device Development of Glide Pharmaceutical Technologies.
4 people are employed at Glide Pharmaceutical Technologies.